Amundi Acquires 1,172,368 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Amundi increased its stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 565.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,379,575 shares of the company's stock after purchasing an additional 1,172,368 shares during the quarter. Amundi owned approximately 0.68% of DocuSign worth $123,486,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of DOCU. KBC Group NV raised its holdings in DocuSign by 209.8% in the 3rd quarter. KBC Group NV now owns 1,156,874 shares of the company's stock worth $71,830,000 after purchasing an additional 783,419 shares during the period. Bank of New York Mellon Corp raised its holdings in DocuSign by 61.5% during the fourth quarter. Bank of New York Mellon Corp now owns 1,673,612 shares of the company's stock valued at $150,525,000 after acquiring an additional 637,505 shares during the period. Fiera Capital Corp bought a new stake in DocuSign during the fourth quarter valued at about $47,920,000. Principal Financial Group Inc. raised its holdings in DocuSign by 3,026.7% during the fourth quarter. Principal Financial Group Inc. now owns 546,796 shares of the company's stock valued at $49,179,000 after acquiring an additional 529,308 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec raised its holdings in DocuSign by 42.4% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,459,580 shares of the company's stock valued at $90,625,000 after acquiring an additional 434,312 shares during the period. 77.64% of the stock is owned by institutional investors.

DocuSign Stock Down 6.8 %

DOCU traded down $5.43 on Thursday, hitting $74.70. The company had a trading volume of 6,981,265 shares, compared to its average volume of 2,197,298. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86. The business's fifty day simple moving average is $88.06 and its 200 day simple moving average is $79.04. The company has a market cap of $15.09 billion, a PE ratio of 15.40, a PEG ratio of 6.94 and a beta of 1.02.

Remove Ads

Insider Buying and Selling at DocuSign

In other news, CEO Allan C. Thygesen sold 40,000 shares of DocuSign stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the completion of the sale, the chief executive officer now owns 156,050 shares of the company's stock, valued at approximately $14,050,742. The trade was a 20.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $86.90, for a total transaction of $695,200.00. Following the sale, the chief financial officer now directly owns 77,851 shares of the company's stock, valued at $6,765,251.90. This represents a 9.32 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 104,422 shares of company stock worth $9,665,394 over the last 90 days. Company insiders own 1.66% of the company's stock.

Wall Street Analyst Weigh In

DOCU has been the topic of a number of recent analyst reports. UBS Group raised their price target on DocuSign from $60.00 to $100.00 and gave the company a "neutral" rating in a report on Friday, December 6th. Citigroup reissued a "buy" rating on shares of DocuSign in a report on Thursday, March 6th. JMP Securities restated a "market outperform" rating and set a $124.00 price objective on shares of DocuSign in a research report on Tuesday, January 7th. Hsbc Global Res upgraded DocuSign to a "moderate sell" rating in a research report on Friday, December 6th. Finally, Royal Bank of Canada restated a "sector perform" rating and set a $90.00 price objective (up previously from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $92.91.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.